Absci Corporation. was rising after a media report about the semiconductor company Advanced Micro Devices investing $20M in the AI drug creation company.
ABSI stock was trading +32% Wednesday pre-market at $4.05, while AMD was -2.8% to $123.76.
The private investment in public equity (PIPE) aims to help AMD increase the use of its AI chips in the healthcare sector, a January 8 report by the Wall Street Journal said.
The PIPE investment also includes an equity stake in Absci, according to the report.
The investment is reportedly Advanced Micro Devices' first attempt to enter the life sciences sector with its AI chips.
Absci is set to move toward greater use of AMD's GPUs, the report noted.
The biotechnology company is set to use the funds from the investment to continue building its AI models and to keep working on its internal drug development efforts, according to WSJ.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。